| scholarly article | Q13442814 |
| P2093 | author name string | Kim JJ | |
| Weiner DB | |||
| Yang JS | |||
| Maguire H | |||
| Hwang D | |||
| Kudchodkar S | |||
| Ramanathan MP | |||
| Dang K | |||
| Choo AY | |||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | West Nile virus | Q158856 |
| P304 | page(s) | 809-816 | |
| P577 | publication date | 2001-08-29 | |
| P1433 | published in | Journal of Infectious Diseases | Q4051141 |
| P1476 | title | Induction of potent Th1-type immune responses from a novel DNA vaccine for West Nile virus New York isolate (WNV-NY1999). | |
| P478 | volume | 184 |
| Q44222584 | A DNA vaccine against foot-and-mouth disease elicits an immune response in swine which is enhanced by co-administration with interleukin-2. |
| Q38714821 | A Novel DNA Vaccine Platform Enhances Neo-antigen-like T Cell Responses against WT1 to Break Tolerance and Induce Anti-tumor Immunity. |
| Q35196530 | A highly optimized DNA vaccine confers complete protective immunity against high-dose lethal lymphocytic choriomeningitis virus challenge. |
| Q33723334 | A multi-head intradermal electroporation device allows for tailored and increased dose DNA vaccine delivery to the skin |
| Q53272516 | A multi-head intradermal electroporation device allows for tailored and increased dose DNA vaccine delivery to the skin. |
| Q37236968 | A review of vaccine approaches for West Nile virus |
| Q57050781 | Assay Challenges for Emerging Infectious Diseases: The Zika Experience |
| Q24677652 | CCR5 deficiency increases risk of symptomatic West Nile virus infection |
| Q35771342 | Cellular immunity induced by a novel HPV18 DNA vaccine encoding an E6/E7 fusion consensus protein in mice and rhesus macaques |
| Q24646031 | Chemokine receptor CCR5 promotes leukocyte trafficking to the brain and survival in West Nile virus infection |
| Q35826774 | Co-Administration of Molecular Adjuvants Expressing NF-Kappa B Subunit p65/RelA or Type-1 Transactivator T-bet Enhance Antigen Specific DNA Vaccine-Induced Immunity |
| Q33847435 | Co-administration of a plasmid DNA encoding IL-15 improves long-term protection of a genetic vaccine against Trypanosoma cruzi |
| Q42410705 | Combined effects of IL-12 and electroporation enhances the potency of DNA vaccination in macaques |
| Q27484655 | Comparative Efficacies of Three Commercially Available Vaccines against West Nile Virus (WNV) in a Short-Duration Challenge Trial Involving an Equine WNV Encephalitis Model |
| Q27481420 | Complex adenovirus-mediated expression of West Nile virus C, PreM, E, and NS1 proteins induces both humoral and cellular immune responses |
| Q35625045 | DNA vaccines for flaviviruses |
| Q36324478 | DNA-based immunotherapy to treat atopic disease |
| Q39828513 | Development of a novel DNA SynCon tetravalent dengue vaccine that elicits immune responses against four serotypes. |
| Q90567311 | Engineered DNA Vaccination against Follicle-Stimulating Hormone Receptor Delays Ovarian Cancer Progression in Animal Models |
| Q40420214 | Enhanced Delivery of DNA or RNA Vaccines by Electroporation |
| Q79602286 | Enhanced cellular immune responses elicited by an engineered HIV-1 subtype B consensus-based envelope DNA vaccine |
| Q98578994 | Enhanced effect of modified Zika virus E antigen on the immunogenicity of DNA vaccine |
| Q39976443 | Enhanced immune response of DNA vaccine (VP1-pCDNA) adsorbed on cationic PLG for foot and mouth disease in guinea pigs |
| Q45355855 | Evaluation of a DNA vaccine candidate co-expressing GP3 and GP5 of porcine reproductive and respiratory syndrome virus (PRRSV) with interferon α/γ in immediate and long-lasting protection against HP-PRRSV challenge |
| Q40341852 | Expression and evolutionary analysis of West Nile virus (Merion strain). |
| Q35209368 | Expression and function of chemokines during viral infections: from molecular mechanisms to in vivo function |
| Q36498186 | Human immunodeficiency virus type 1 vaccine development: recent advances in the cytotoxic T-lymphocyte platform "spotty business". |
| Q27489722 | IL-10 Signaling Blockade Controls Murine West Nile Virus Infection |
| Q24630281 | IL-28B/IFN-lambda 3 drives granzyme B loading and significantly increases CTL killing activity in macaques |
| Q40433851 | Immune response in guinea pigs vaccinated with DNA vaccine of foot-and-mouth disease virus O/China99. |
| Q34511132 | Immunization of mice with recombinant mosquito salivary protein D7 enhances mortality from subsequent West Nile virus infection via mosquito bite |
| Q44241050 | Immunogenicity of a Japanese encephalitis DNA vaccine candidate in cynomolgus monkeys |
| Q33576984 | Immunogenicity of a novel engineered HIV-1 clade C synthetic consensus-based envelope DNA vaccine |
| Q36256428 | Immunogenicity of a novel enhanced consensus DNA vaccine encoding the leptospiral protein LipL45 |
| Q30359911 | Immunogenicity of novel consensus-based DNA vaccines against avian influenza. |
| Q35771332 | Induction of antitumor immunity in vivo following delivery of a novel HPV-16 DNA vaccine encoding an E6/E7 fusion antigen |
| Q27489551 | Induction of inflammation by West Nile virus capsid through the caspase-9 apoptotic pathway |
| Q30414135 | Influenza A vaccines using linear expression cassettes delivered via electroporation afford full protection against challenge in a mouse model |
| Q34542855 | Innate and Adaptive Immune Responses Determine Protection against Disseminated Infection by West Nile Encephalitis Virus |
| Q80204825 | Intradermal/subcutaneous immunization by electroporation improves plasmid vaccine delivery and potency in pigs and rhesus macaques |
| Q27477543 | Pathogenesis of West Nile Virus Infection: a Balance between Virulence, Innate and Adaptive Immunity, and Viral Evasion |
| Q26247032 | Production of immunogenic West Nile virus-like particles using a herpes simplex virus 1 recombinant vector |
| Q40325834 | Protection provided by a recombinant ALVAC(®)-WNV vaccine expressing the prM/E genes of a lineage 1 strain of WNV against a virulent challenge with a lineage 2 strain. |
| Q30395101 | Prototype development and preclinical immunogenicity analysis of a novel minimally invasive electroporation device. |
| Q39683189 | Recognition of the measles virus nucleocapsid as a mechanism of IRF-3 activation |
| Q33632017 | Recombinant DNA and Protein Vaccines for Foot-and-mouth Disease Induce Humoral and Cellular Immune Responses in Mice |
| Q36411126 | Repeated in vivo stimulation of T and B cell responses in old mice generates protective immunity against lethal West Nile virus encephalitis |
| Q35702678 | Structure and function of the 3' terminal six nucleotides of the west nile virus genome in viral replication |
| Q42985686 | The emergence of West Nile virus in Canada. |
| Q27486421 | The relative contribution of antibody and CD8+ T cells to vaccine immunity against West Nile encephalitis virus |
| Q40049457 | Vaccine development for emerging virulent infectious diseases |
| Q40428683 | Vero cell-derived inactivated West Nile (WN) vaccine induces protective immunity against lethal WN virus infection in mice and shows a facilitated neutralizing antibody response in mice previously immunized with Japanese encephalitis vaccine |
| Q34335105 | West Nile virus vaccines |
| Q35746093 | West Nile virus: a growing concern? |
| Q35036664 | West nile virus: current perspectives. |
Search more.